Synthesis of multifunctional nanoparticles for biomedical applications
The Laboratory of Immunology, Immunopathology and Therapeutic Chemistry (CNRS, Strasbourg, France) is expert in the synthesis and chemical functionalization of different types of inorganic nanoparticles (e.g., Prussian blue nanoparticles, magnetic and plasmonic nanoparticles) and carbon-based nanomaterials, such as carbon nanotubes, for biomedical applications (anticancer therapy, treatment of autoimmune diseases, antibacterial applications). Our research interests are also focused on the self‑assembly of amino acid derivatives and peptides to form nanoparticles and hydrogels for on‑demand drug delivery for the treatment of cancer or plant diseases. In addition, we investigate the biodegradability of nanoparticles and their potential toxicity.
Who can apply?
- Researchers of any nationality who have completed a PhD or will complete it by the call deadline (September 2026).
- Have a maximum of 8 years full‑time equivalent experience in research at the time of the call deadline.
- Have not resided or carried out their main activity (work, studies, etc.) in France for more than 12 months in the 3 years immediately prior to the call deadline.
Beware that applicants who have applied to the MSCA Postdoctoral Fellowship 2025 call and received an evaluation below 80% are not eligible for an application in 2026.
How to apply?
We encourage all motivated and eligible postdoctoral researchers to send their expressions of interest to the supervisor’s e‑mail address before 24th April 2026.
Your application shall include:
- a CV (5 pages max)
- a cover letter outlining your research background and its synergies with the supervisor’s field and/or the proposed research topic.
Estimated timetable:
- Deadline for sending an expression of interest: 24th April 2026
- Selection of the applicant: May 2026 at the latest